Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus pilot study in Peutz-Jeghers syndrome-related advanced malignancies or high-risk polyps
NL-OMON36695Phase 2Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of everolimus in Peutz-Jeghers syndrome (PJS) (2 cohorts), sponsored by Amsterdam University Medical Center. Primary endpoint: Objective tumor response. Started Sep 2012; status: active, not recruiting.
02
Drugs
everolimus
03
Conditions
Peutz-Jeghers syndrome (PJS)
Beyond the preview
Go deeper on NL-OMON36695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36695.